HOME | Career | Contact us | Safety Reporting
 
 
Products
 
PATIENTS > Soventus-DC Suspension
Soventus-DC Suspension
Composition: Each 5 ml of Suspension contains: Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine Fendizoate 20 mg.

Indications: Symptomatic treatment of cough associated with acute and chronic respiratory disorders.

Adverse events: Minor and transient adverse reactions such as GI effects, exhaustion,faintness, somnolence, clouding of consciousness, numbness,dizziness, headache and palpitations.

Contraindications: Hypersensitivity to any of the component of the formulation, pregnancy, early childhood, consumption along with alcohol.

Precautions: Should be used with caution in hypertension, cardiovascular disease, uncontrolled diabetes mellitus, hyperthyroidism, seizures, hypersensitivity to sympathomimetic amines, along with antihistaminics, sedatives and tranquilizers.

Dosage and administration: Adults - 5 ml three times daily. (For detailed information please write to Zuventus Healthcare Limited, 5119, 5th floor, D-Wing, Oberoi Garden Estates, Chandivali, Andheri (E), Mumbai 400 072 or email to medico@zuventus.com).


 
 
Back
 
© 2013. All Rights Reserved. Zuventus HealthCare Ltd.